Privia Health Group (NASDAQ:PRVA) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?

Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $22.63 and traded as high as $23.98. Privia Health Group shares last traded at $23.94, with a volume of 3,338,673 shares.

Privia Health Group News Summary

Here are the key news stories impacting Privia Health Group this week:

Analyst Upgrades and Downgrades

PRVA has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a research report on Tuesday, September 29th. Citigroup restated a “buy” rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 5th. Finally, Canaccord Genuity Group set a $32.00 target price on Privia Health Group in a report on Friday, August 7th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Privia Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.00.

Check Out Our Latest Report on PRVA

Privia Health Group Trading Up 6.9%

The business’s 50 day simple moving average is $20.97 and its 200 day simple moving average is $22.63. The firm has a market capitalization of $3.06 billion, a PE ratio of 114.01 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.12. The business had revenue of $656.96 million during the quarter, compared to analyst estimates of $610.72 million. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%. The company’s revenue for the quarter was up 13.2% on a year-over-year basis. During the same period last year, the company earned $0.29 EPS. Analysts forecast that Privia Health Group, Inc. will post 0.27 earnings per share for the current year.

Hedge Funds Weigh In On Privia Health Group

A number of large investors have recently bought and sold shares of the business. Public Employees Retirement System of Ohio bought a new position in Privia Health Group in the 2nd quarter worth about $26,000. Heritage Family Offices LLP purchased a new stake in shares of Privia Health Group during the 3rd quarter worth $34,000. Parallel Advisors LLC boosted its holdings in shares of Privia Health Group by 313.7% in the 3rd quarter. Parallel Advisors LLC now owns 2,180 shares of the company’s stock valued at $43,000 after buying an additional 1,653 shares in the last quarter. Allworth Financial LP purchased a new position in Privia Health Group in the second quarter worth $48,000. Finally, Nykredit A S purchased a new position in Privia Health Group during the 2nd quarter worth $50,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

About Privia Health Group

(Get Free Report)

Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices.

Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.

Read More

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.